Buyback27 Apr 2026, 07:42 am
Jagsonpal Pharma: Shareholders Approve ₹40 Cr Buyback
AI Summary
Jagsonpal Pharmaceuticals Ltd. announced that shareholders have approved the buyback of up to 16 lakh equity shares at ₹250 per share, aggregating up to ₹40 Crores. This buyback aims to enhance shareholder value through optimized capital allocation and improved earnings per share. The company will communicate further details regarding timelines and record date in due course.
Key Highlights
- Shareholders approved Jagsonpal Pharma's buyback proposal.
- The buyback involves up to 16 lakh shares at ₹250 each.
- The total buyback amount is capped at ₹40 Crores.
- The buyback aims to optimize capital allocation and improve EPS.
- Timelines and record date will be announced later.